Comment on “Gene expression profiling in dermatology, part 2: Clinical applications—Toward safe, patient-centered implementation” - 18/06/26
Doi : 10.1016/j.jaad.2025.12.128
Yixuan Li, MSc a, Ying Wang, PhD b, c, d, ⁎ 
a The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou First People's Hospital, Hangzhou, China
b Clinical Research Center, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China
c Laboratory of Medicine, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China
d Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China
∗ Correspondence to: Ying Wang, PhD, Hangzhou First People's Hospital, No. 261 Huansha Road, Shangcheng, Hangzhou, China Hangzhou First People's Hospital No. 261 Huansha Road Shangcheng Hangzhou China
Key words : clinical implementation, gene expression profiling, health equity, melanoma, molecular diagnostics
Abbreviation used : GEP
Le texte complet de cet article est disponible en PDF.
| Funding sources: None. |
|
| IRB approval status: Not applicable. |
|
| Patient consent: Not applicable. |
© 2026
Publié par Elsevier Masson SAS.
Vol 95 - N° 1
P. e63-e64 - juillet 2026 Retour au numéro
Article précédent
- Dermoscopic diagnostic limitations extend beyond ChatGPT into other large language models
- Isha Gandhi, Rashika Shetty, Lana Kamel, Ruizhi Zhang, Nick Dol, Robert Adler, Chase Fishman, Steven Fishman
- Response to Li et al’s “Comment on ‘Gene expression profiling in dermatology, part 2: Clinical applications’—toward safe, patient-centered implementation”
- Stanislav N. Tolkachjov
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?